Here are five things to know.
1. The framework breaks down the value of drugs into two main concepts: long-term value for money and short-term affordability.
2. Aspects of long-term value include comparative clinical effectiveness, incremental cost-effectiveness, contextual considerations and other benefits or disadvantages. Short-term affordability focuses on potential budget impact, according to the report.
3. More than 50 organizations submitted more than 300 pages of comments and suggestions for the framework during a national public comment period in late 2016, according to the report.
4. ICER hopes the framework will help inform decisions aimed at achieving sustainable access to high value care for all patients, according to the report.
5. The nonprofit is taking on an influential role in the drug industry — payers already cite ICER’s work when negotiating prices with drug companies, reports STAT.
More articles on supply chain:
Shifting drug production back to US could raise prices: 5 takeaways
5 ways to prepare your supply chain for a disaster
Mayo Clinic physician: A stripped down FDA would be ‘chaotic’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
